Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Intestinal flora marker for predicting curative effect of immunotherapy and application of intestinal flora marker

A technology of intestinal flora and immunotherapy, applied in the field of immunotherapy, can solve the problems of analyzing species and difficult bacteria, achieve the effect of large individual differences, multiple detection targets, and avoid the disadvantages of single index detection

Pending Publication Date: 2022-02-25
SUN YAT SEN UNIV CANCER CENT
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Metagenomic sequencing can comprehensively analyze intestinal flora, but this technology has the disadvantage of being difficult to analyze bacteria into species
According to the sequencing research results of Routy et al., only Akkermansia muciniphila was found among the bacteria with significant statistical differences at the species level; most of the other bacteria with differences were at the level of phylum, family or genus; and Firmicutes, Lachnospiraceae and Erysipelotrichaceae were also effective in immunotherapy Highly expressed in the group and progression-free survival <3 months group, which makes it difficult to accurately judge or interpret the sequencing results

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Intestinal flora marker for predicting curative effect of immunotherapy and application of intestinal flora marker
  • Intestinal flora marker for predicting curative effect of immunotherapy and application of intestinal flora marker
  • Intestinal flora marker for predicting curative effect of immunotherapy and application of intestinal flora marker

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0085] According to the current research results, a single detection index is difficult to effectively predict the efficacy of immunotherapy, and there is a high false positive or false negative rate. As a biomarker, intestinal flora has the advantages of large individual differences and multiple detection targets. Based on the detection method of real-time fluorescence quantitative PCR, the present invention screens 55 detection targets of intestinal bacterial genome DNA, and obtains 5 scoring formulas that can be used to predict the curative effect of immunotherapy. The relative expression level and scoring of targets can predict the efficacy of immunotherapy in melanoma patients with different drug regimens. The specific detection targets and their numbers are as follows:

[0086]

[0087] Due to the particularity of stool samples, the amount of samples collected or added cannot reach the same degree of standardization as that of blood and urine samples, so it is diffic...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an intestinal flora marker for predicting the curative effect of immunotherapy and application of the intestinal flora marker. The inventor screens out DNA detection targets with expression differences in patients with different clinical effects from 55 intestinal bacterium DNA detection targets, and can solve the problems that few biomarkers can be available for melanoma immunotherapy patients and the effect is not ideal. The relationship between the intestinal flora characteristics and the PD-1 / PD-L1 blocking treatment may have generality in different types of tumors; the research results of the project have the possibility of being applied to tumors except melanoma, such as sarcoma, kidney cancer, lung cancer, stomach cancer or colorectal cancer, and benefiting patients through data supplementation and reanalysis.

Description

technical field [0001] The present invention relates to the field of immunotherapy, in particular to intestinal flora markers and applications thereof for predicting the curative effect of immunotherapy. Background technique [0002] Compared with traditional treatment schemes, immunotherapy has the advantages of longer maintenance time in the body and less side effects. Although immunotherapy has achieved great success in the treatment of tumors, its effective rate is still low; the effective rate of immunotherapy for melanoma and soft tissue sarcoma is about 30%, which is not a very high rate compared with traditional treatment. efficiency. Screening patients who can benefit from immunotherapy is the key to successful treatment. Currently, the indicators that can be used to predict the efficacy of immunotherapy include tumor PD-L1 expression level and tumor mutation burden (TMB), but they are still inconclusive; immunotherapy patients face Given the lack of available bio...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12Q1/689C12Q1/02
CPCC12Q1/689C12Q1/025C12Q2600/158C12Q2600/178C12Q2600/166G01N2800/7028G01N2800/52
Inventor 欧国平刘万里李婧婧张晓实郑海林朱苑莹
Owner SUN YAT SEN UNIV CANCER CENT
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products